Testing effectiveness (Phase 2)Study completedNCT05551598
What this trial is testing
Efficacy and Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD)
Who this might be right for
Neuromyelitis Optica Spectrum Disorder
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 46